Jong-Ju Park1, Hun-Ki Seong1, Jeong-Soo Kim1, Byambaragchaa Munkhzaya1, Myung-Hwa Kang2, Kwan-Sik Min1. 1. Animal Biotechnology, Graduate School of Future Convergence Technology, Department of Animal Life Science, Institute of Genetic Engineering, Hankyong National University, Ansung 17579, Korea. 2. Department of Food Science and Nutrition, Hoseo University, Asan 31499, Korea.
Abstract
Equine chorionic gonadotropin (eCG) is a unique molecule that elicits the response characteristics of both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in other species. Previous studies from this laboratory had demonstrated that recombinant eCG (rec-eCG) from Chinese hamster ovary (CHO-K1) cells exhibited both FSH- and LH-like activity in rat granulosa and Leydig cells. In this study, we analyzed receptor internalization through rec-eCGs, wild type eCG (eCGβ/α) and mutant eCG (eCGβ/αΔ56) with an N-linked oligosaccharide at Asn56 of the α-subunit. Both the rec-eCGs were obtained from CHO-K1 cells. The agonist activation of receptors was analyzed by measuring stimulation time and concentrations of rec-eCGs. Internalization values in the stably selected rat follicle-stimulating hormone receptor (rFSHR) and rat luteinizing/chorionic gonadotropin receptor (rLH/CGR) were highest at 50 min after stimulation with 10 ng of rec-eCGβ/α. The dose-dependent response was highest when 10 ng of rec-eCGβ/α was used. The deglycosylated eCGβ/αΔ56 mutant did not enhance the agonist-stimulated internalization. We concluded that the state of activation of rFSHR and rLH/CGR could be modulated through agonist-stimulated internalization. Our results suggested that the eLH/CGRs are mostly internalized within 60 min by agonist-stimulation by rec-eCG. We also suggested that the lack of responsiveness of the deglycosylated eCGβ/ αΔ56 was likely because the site of glycosylation played a pivotal role in agonist-stimulated internalization in cells expressing rFSHR and rLH/CGR.
Equinechorionic gonadotropin (eCG) is a unique molecule that elicits the response characteristics of both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in other species. Previous studies from this laboratory had demonstrated that recombinant eCG (rec-eCG) from Chinese hamster ovary (CHO-K1) cells exhibited both FSH- and LH-like activity in rat granulosa and Leydig cells. In this study, we analyzed receptor internalization through rec-eCGs, wild type eCG (eCGβ/α) and mutant eCG (eCGβ/αΔ56) with an N-linked oligosaccharide at Asn56 of the α-subunit. Both the rec-eCGs were obtained from CHO-K1 cells. The agonist activation of receptors was analyzed by measuring stimulation time and concentrations of rec-eCGs. Internalization values in the stably selected ratfollicle-stimulating hormone receptor (rFSHR) and rat luteinizing/chorionic gonadotropin receptor (rLH/CGR) were highest at 50 min after stimulation with 10 ng of rec-eCGβ/α. The dose-dependent response was highest when 10 ng of rec-eCGβ/α was used. The deglycosylated eCGβ/αΔ56 mutant did not enhance the agonist-stimulated internalization. We concluded that the state of activation of rFSHR and rLH/CGR could be modulated through agonist-stimulated internalization. Our results suggested that the eLH/CGRs are mostly internalized within 60 min by agonist-stimulation by rec-eCG. We also suggested that the lack of responsiveness of the deglycosylated eCGβ/ αΔ56 was likely because the site of glycosylation played a pivotal role in agonist-stimulated internalization in cells expressing rFSHR and rLH/CGR.
Equinechorionic gonadotropin (eCG) is a unique member of the gonadotropin family, as
it can perform both LH- and FSH-like activity in non-equid species as well (Apparailly and Combarnous, 1994; Chopineau et al., 2001). Members of the
glycoprotein family, which includes chorionic gonadotropin (CG), luteinizing hormone
(LH), follicle-stimulating hormone (FSH), and thyroid-stimulating hormone (TSH),
comprise two non-covalently linked α- and β-subunits (Min et al., 2004; Park et al.,
2010). The β-subunits of eCG and eLH have identical primary structures
(Min et al., 1994). Thus, eCG could be an ideal model for studying
structure/function relationships of gonadotropins, as it exhibits the properties of
both its pituitary and placental counterparts (Guillou and Combarnous, 1983; Galet et
al., 2009).In mares, eCG is secreted from binucleate trophoblastic cells, called endometrial
cups, in maternal plasma during the first half of equine gestation. These cells
detach from the chorionic girdle of the conceptus between days 37–120 of pregnancy
(Boeta and Zarco, 2012; Flores-Flores et al., 2014; Conley, 2016). Progesterone has not been
detected in the second half of gestation in mares (Conley, 2016). The presence of eCG during pregnancy may have a
luteogenic effect, leading to the formation of supplementary CL after 35 days of
pregnancy as a result of the ovulation and/or luteinization of dominant follicles at
different times (Allen, 2001a). Previous
studies on biological activity of rec-eCG, rec-eCGβ/α also had higher in
vitro bioactivity than the eLH (Min et
al., 1996). Deletion of carboxy-terminal peptides (CTP) from the dimeric
eCG induced a 50% decrease in the secretion of the truncated hormone, compared to
the wild type (Galet et al., 2000). The
protein was truncated downstream of residue 109, which significantly decreased its
secretion. Thus, the CTP upstream of the residues of the eCGβ-subunit at the
'seat-belt' region were also involved in the folding and secretion of gonadotropins
(Galet et al., 2009).In our previous study, we had produced rec-eCG from CHO-K1 cells, which were shown to
exhibit dual LH- and FSH-like activity in rat Leydig and granulosa cells (Min et al., 1996, 2004), which expressed rLH/CGR and rFSHR (Park et al., 2009, 2010;
Jeoung et al., 2010). A deletion
downstream of amino acid 87 of the eCGα-subunit resulted in it not being secreted
into the supernatant of the medium in both the transiently and stably transfected
cells (Jeoung et al., 2010). A mutant with a
deletion downstream of amino acid 95 of the eCGα-subunit showed no LH-like or
FSH-like activities, indicating that the C-terminal region of the eCGα-subunit plays
a pivotal role in the activity of cells expressing the rFSHR and rLH/CGR. We had
also reported that the amino acid sequence at 94–96 of eCGβ-subunit appeared to be
very important for signal transduction of the FSHR (Park et al., 2010).Along with the FSHR, LH/CGR is a member of the rhodopsin-like subfamily of
G-protein-coupled receptors (GP CRs), which has been shown to mediate the
internalization of its agonist (Segaloff and Ascoli,
1993; Ascoli et al., 2002; Flores-Flores et al., 2014). The internalized
receptors are either degraded in lysosomes (Ghinea
et al., 1992) or undergo resensitization and reinsertion into the plasma
membrane (Ascoli and Segaloff, 1987; Lazari et al., 1998). Thus, the majority of
internalized GPCRs are recycled back to the plasma membrane, instead of being routed
to the lysosomes. Thus, internalization is thought to play an important role in
receptor resensitization, rather than desensitization (Krupnick and Benovic, 1998; Lefkowitz, 1998).We also reported on the function of the deglycosylated rec-eCGs produced from CHO-K1
cells (Min et al., 1996, 2004). However, we did not revealed the
specific factors for the reduced biological activity in receptor cells. To better
define the involvement of the biological activity of the rec-eCG stimulated cAMP
synthesis, we have now analyzed the internalization of the rFSHR and rLH/CGR by
deglycosylated rec-eCG. In the present study, we constructed a mammalianexpression
vector of rFSHR and rLH/CGR. The expressing vectors transfected to CHO-K1 cell and
assessed the internalization of rFSHR and LHR by the bound rec-eCGβ/α.
MATERIALS AND METHODS
1. Materials
The expression vector pcDNA3 was purchased from Invirogen (CA, USA). CHO-K1
cells were obtained from the Japanese Cancer Research Resources Bank (Tokyo,
Japan). Endonucleases were Boehringer Mannheim (MA, USA) and Takara (Osaka,
Japan). Polymerase chain reaction (PCR) reagents were from Takara (Japan). Ham's
F-12, CHO-S-SFM II, Geneticin, Lipofectamine 2000 and fetal bovineserum (FBS)
were from Gibco BRL (MD, USA). The QIAprep-Spin plasmid kit was purchased from
QIAGEN Inc. (Hilden, Germany). PMSG enzyme-linked im-munosorbent assay (ELISA)
kit was from DRG (USA). The pCORON 1000 SP VSV-G tag expression vector, cAMP kit
and CypHer 5-labeled anti-VSVG were from GE Healthcare Life Science
(Buckinghamshire, UK). The oligonucleotides were synthesized by Green Gene Bio
(Seoul, Korea). Fetal bovineserum was from Hyclone laboratories (Utah, USA).
Centriplus Centrifugal Filter Devices were purchased from Amicon Bio separations
(MA, USA). All other reagents used were from Sigma-Aldrich (USA) and Wako Pure
Chemicals (Osaka, Japan).
2. Construction of the tethered eCGβ/α and eCGβ/ αΔ56
cDNAs encoding the tethered eCGβ/α were inserted in the pcDNA3 mammalianexpression vector and used as templates to construct the mutants, in which
Asn56 (AAC) at the glycosylated site of the α-subunit was
substituted for Gln (CAG), as previously reported (Min et al., 2004). The epitope, myc-tag
(Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu), inserted into the tethered eCGβ/α and
mutant (eCGβ/ αΔ56) between the first and second amino acids in the β-subunit of
the mature protein. Site-directed mutagenesis was performed using the three
primers method in a single-step PCR (Min et al.,
2004). The schematic diagrams of rec-eCGβ/αWT and eCGβ/αΔ56 are shown
in Fig. 1. These fragments were digested
with EcoR I and Sal I and ligated into the
eukaryotic expression vector, pcDNA3. The plasmids were then purified and
sequenced in both directions by automated DNA sequencing to ensure that the
correct mutations had been introduced (designated as pcDNA3-eCGβ/α; β/αΔ56).
Fig. 1
Fig. 1. Schematic diagram of rec-eCGβ/α and receCGβ/ αΔ56.
The eCG cDNA was ligated into the pcDNA3 mammalian expression vector.
Wild type (eCGβ/α) and eCGβ/αΔ56 (deglycosylated at Asn56 in
the α-subunit replaced with Gln) were constructed.
Fig. 1. Schematic diagram of rec-eCGβ/α and receCGβ/ αΔ56.
The eCG cDNA was ligated into the pcDNA3 mammalianexpression vector.
Wild type (eCGβ/α) and eCGβ/αΔ56 (deglycosylated at Asn56 in
the α-subunit replaced with Gln) were constructed.
3. Cell culture and functional expression
Cultured CHO-K1 cells were transfected into expression vectors using the liposome
transfection method, as pre-viously described (Min et al., 2004). The transfected cells were cultured for 48 h in a
serum-free medium (CHO-S-SFM-II) and then harvested and centrifuged at 15,000
rpm for 10 min. The supernatant was collected and stored at −20℃ until the
assay. Six to 8 pools of stably transfected cells were selected by incubating
the cells in a growth medium [Ham’s F12 medium with 10% FCS, penicillin (100
IU/mL), streptomycin (100 μg/mL) and glutamine (2 mM) supplemented with G418
(800 μg/mL)] for 2–3 weeks after transfection, as previously reported method
(Min et al., 2004). The culture
medium was centrifuged at 15,000 rpm for 10 min to remove cell debris. The
supernatant was collected and concentrated in an Amicon Stirred cell
concentrator and stored at −20℃ until the assay.
4. Quantification of rec-eCG proteins
The tethered eCG proteins secreted by the transient transfected CHO-K1 cells and
the stable cell lines into serum-free media were collected, and rec-eCG was
quantified using the PMSG ELISA (enzyme-linked immunosorbent assay) kit,
according to the supplier's protocol (DRG, USA). Briefly, the collected medium
was dispensed into wells coated with a monoclonal antibody against unique
antigenic site on the eCG molecule. The wells were incubated for 60 min at RT
and 100 µL of conjugate was then added into each well. The substrate solution
(100 µL) was also added, and the mixture was then incubated for 30 min at RT.
Finally, 50 µL stop solution was added to stop the enzymatic reaction. The
optical density (OD) of the product solution was read at 450 nm with a micro
titer plate reader.
5. Selection of cell lines expressing rLH/CGR and rFSHR
The cDNAs for rLH/CGR and FSHR were cloned and expressed in CHO-K1 cell lines, as
previously described (Min et al., 1998;
Min, 1999). The receptor cDNAs were
subcloned into the eukaryotic expression vector, pCORON 1000 SP VSV-G tag (GE
Healthcare Life Science, Buc-kinghamshire, UK), for transfection. Stably
transfected cell lines were selected by G418 treatment, as previously described
(Min et al., 2004, Seo et al., 2015). Briefly, cloned cells
were cultured in standard 96-well microplates at concentrations of
105–106 cells/mL and incubated overnight. Cholera
toxin was added and the mixture was incubated for 30 min. Finally, the cyclic
AMP kit was used according to the supplier's protocol, and the OD was measured
at 630 nm with a microplate reader. The establishment and pro-perties of a
clonal cell line expressing vsvg-rLH/CGR-wt [designated as
vsvg-rLH/CGR (wt-9)] and one expressing
vsvg-rFSH-wt [designated vsvg-rFSHR
(wt-7)] were studied based on cAMP responsiveness to an agonist, cholera toxin,
as previously reported (Park et al.,
2009).
6. Internalization assays of rLH/CG and rFSH receptors by rec-eCGs
A novel assay technology, which relies on the intrinsic ability of cell surface
receptors to internalize into acidic endosomal vesicles upon agonist
stimulation, was recently reported (Lowe et al.,
2015). This technology uses a novel, fluorogenic, pH-sensitive
cyanine dye, CypHer 5. It is there- fore ideal for reporting the movement of
receptors from the cell surface into the acidic internal endosomes. The rLH/CGR
cells and FSHR cells were seeded into a 96-well tissue culture view plate
(Perkin Elmer; 6005710, pre-coated with poly-D-lysine) at a density of
2×103 cells/cm2 in a complete Nutrient Mix F-12 Ham’s
medium with G418 (700 µg/mL). The cells were incubated at 37℃ overnight until
the cells were 20–40% confluent. The supernatant was removed and the cells
gently washed twice with Kreb's Ringer Buffer (KRB) (120 mM sodium chloride, 25
mM HEPES, 4.8 mM potassium chloride, 1.2 mM potassium dihydrogen orthophosphate,
1.2 mM magnesium sulphate heptahydrate, and 1.3 mM calcium chloride) at pH 7.4.
The culture medium was replaced with 70 µL/ well of KRB. KRB with
CypHer5-labeled antibodies (2-5 µg/mL), 1μM Hoechst 33342, and 1% FBS was then
added to the plate. After incubating at RT for 10 min, 30 µL of KRB containing
the agonist (1, 3, 6, 10, and 20 ng/mL of rec-eCG and 500 ng/mL of cholera
toxin) was added to the plate. The mixture was incubated at RT for 60 min, and
75 μL/well of ice-cold 8% paraformaldehyde was then added. After incubating on
ice at 4℃ for 20 min, the supernatant was removed and the cells were gently
washed twice with PBS. Finally, 100 μL/well of PBS was added. The Cy5-labeled
receptors and the Hoechst 33342 were visualized with the In Cell Analyzer 3000
device (GE Healthcare Life Science, Buckinghamshire, UK).
RESULTS
1. Stable expression rec-eCGβ/α and rec-eCGβ/α Δ56
The eCGβ/α and rec-eCGβ/αΔ56 vectors were transfected into CHO-K1 cells and the
cells stably expressing genes were then selected with G418 treatment. The
rec-eCGs secreted by the stably transfected cells into the serum-free medium
were isolated and concentrated. The rec-eCGs were quantified using ELISA. The
quantity of rec-eCG obtained from stably transfected cells was about 180-240
mIU/mL. The size of the rec-eCGβ/α protein was found to be approximately 40-45
kDa (data now shown), which was consistent with previous studies (Park et al., 2009, 2010; Jeoung et al.,
2010). However, the size of the rec-eCG secreted by the mutant with
the deglycosylated Asn56 in the α-subunit was decreased approximately
4-5 kDa.
2. Isolation of CHO-K1 cell lines stably expressing rFSHR and rLH/CGR
The mammalianexpression vectors for rFSHR and rLH/ CGR were transfected into
CHO-K1 cells. The 10 clones were then isolated by G418 treatment. The cAMP level
was determined to evaluate the response for agonist stimulation. The most
stimulated cells were rFSHR-7 and rLH/ CGR-9, as shown in Fig. 2. The maximal cAMP responses were 2,100 pmol/mL and
3,500 pmol/mL in the rFSHR and rLH/CGR, respectively.
Fig. 2
Selection of cells expressing rFSHR and rLH/ CGR from stably
transfected CHO-K1 cells.
Cloned cells were cultured at concentrations of
105-106 cells/mL. Cholera toxin (100 ng/mL)
was added, incubated, and cyclic AMP was analyzed using a cAMP kit.
Selection of cells expressing rFSHR and rLH/ CGR from stably
transfected CHO-K1 cells.
Cloned cells were cultured at concentrations of
105-106 cells/mL. Cholera toxin (100 ng/mL)
was added, incubated, and cyclic AMP was analyzed using a cAMP kit.
3. Internalization assay results of receptors by rec-eCGs in time- and
concentration-dependent manner
The effects of rec-eCGβ/α on the internalization of rFSHR and rLH/CGR in CHO-K1
cells were determined in a time-dependent manner (0–70 min). As shown in Fig. 3A, rFSHRrLH/CGR were most internalized
at 50 min after incubating rec-eCGβ/α (10 ng/mL). We also measured the effect of
rec-eCGβ/α on the internalization by receptors in a concentration-dependent
manner (Fig. 3B), and found that the
internalization increased proportional to the concentration of rec-eCGβ/α. The
granularity values for both the receptors were found to be 800–900. The results
of the agonist activation experiment also suggested that both the receptors were
internalized in endosomes. Therefore, we used Cy5-labeled receptors to detect
the localization after 60 min of incubation with rec-eCGβ/α (Fig. 4). Next, we analyzed the differences
between the effects of rec-eCGβ/α and rec-eCGβ/αΔ56 on stably expressed these
receptors (rFSHR-7 and rLH/CGR-9). The results of this analysis showed that the
rec-eCGβ/αΔ56 in cells expressing rFSHR and rLH/CGR was completely flat; no
agonist-stimulated internalization was induced in either cell type by eCGβ/αΔ56
(Fig. 5A, B). Together, these data
suggested that rec-eCGβ/α induced receptor internalization in cells expressing
rFSHR and rLH/CGR. However, the mutant with the eCGβ/αΔ56 did not induce this
agonist stimulated internalization. Thus, the glycosylation site
(Asn56) in the eCGα- subunit played a pivotal role in receptor
internalization.
Fig. 3
Internalization results for cells expressing rFSHR and
rLH/CGR.
(A) Internalization results for time-dependent (0–70 min) at a fixed
rec-eCGβ/α concentration (10 ng/mL) in rFSHR and rLH/CGR. (B)
Internalization results for agonist-dependent (1–20 ng/mL). The rLH/CGR
cells (wt-9) and FSHR cells (wt-7) cells were seeded at a density of
2×103 cells. The results were visualized using the In
Cell Analyzer 3,000 device and the granularity of the receptors
internalized into the endosomes was calculated.
Fig. 4
Visualization of internalization results with In Cell Analyzer 3000
device.
The cells were labeled with CypHer5 antibody and the agonist (rec-eCGβ/α)
was added, as shown in Fig. 3. The
Cy5-labeled receptors and the Hoechst 33342 were visualized using the In
Cell Analyzer 3,000 device.
Fig. 5
Internalization results of rec-eCGβ/α and rec-eCGβ/αΔ56 using cells
expressing rFSHR and rLH/CGR.
(A) rFSHR cells. (B) rLH/CGR cells. Both rec-eCGβ/α and rec-eCGβ/αΔ56
were induced by stably transfected rFSHR and rLH/CGR cells.
Internalization assays were analyzed in a rec-eCGβ/ α-dose-dependent
manner, as described in Fig. 3.
Internalization results for cells expressing rFSHR and
rLH/CGR.
(A) Internalization results for time-dependent (0–70 min) at a fixed
rec-eCGβ/α concentration (10 ng/mL) in rFSHR and rLH/CGR. (B)
Internalization results for agonist-dependent (1–20 ng/mL). The rLH/CGR
cells (wt-9) and FSHR cells (wt-7) cells were seeded at a density of
2×103 cells. The results were visualized using the In
Cell Analyzer 3,000 device and the granularity of the receptors
internalized into the endosomes was calculated.
Visualization of internalization results with In Cell Analyzer 3000
device.
The cells were labeled with CypHer5 antibody and the agonist (rec-eCGβ/α)
was added, as shown in Fig. 3. The
Cy5-labeled receptors and the Hoechst 33342 were visualized using the In
Cell Analyzer 3,000 device.
Internalization results of rec-eCGβ/α and rec-eCGβ/αΔ56 using cells
expressing rFSHR and rLH/CGR.
(A) rFSHR cells. (B) rLH/CGR cells. Both rec-eCGβ/α and rec-eCGβ/αΔ56
were induced by stably transfected rFSHR and rLH/CGR cells.
Internalization assays were analyzed in a rec-eCGβ/ α-dose-dependent
manner, as described in Fig. 3.
DISCUSSIONS
The results of the present study showed that rec-eCGβ/α induced the internalization
of rFSHR and rLH/CGR in CHO- K1 cell lines that expressed those receptors in a time-
and con- centration- dependent manner. We also showed that deglycosylation at
Asn56 of the α-subunit of rec-eCGβ/α inhibited this agonist-induced
internalization in both cell types.Previous studies have demonstrated that rec-eCGβ/α was expressed in the
baculovirus-Sf9 insect cell system, either as a single-chain with the C-terminal of
the β-sub-unit fused to the N-terminus of the α-subunit or as non-covalently linked
heterodimers with or without polyhistidine tags at various locations (Legardinier et al., 2008). Heterodimeric
rec-eCG exhibited the same thermal stability as natural pituitary LH, and its
advantages over the single-chain eCG included higher secretion, higher in
vitro bioactivity, and lower risk of immunogenicity (Legardinier et al., 2008). From the labeling
and pulse-chase experiments, the secretion of the eCGβ-subunit from CHO-K1 cells was
inefficient (medium recovery of 16–25%) and slow (t1/2>6.5 h). This
secretion of eCGβ-subunit resembled that of hLHβ-subunit, rather than that of the
hCGβ-subunit (Cohen et al., 2015). In a
previous study, rec-eCG was expressed in commercially available MimicTM
insect cells that were stably transformed into Sf9 cells expressing five mammalian
genes that encoded glycosyltransferases involved in the synthesis of complex-type
monosialylated N-glycans. the rec-eCG produced from these MinicTM insect
cells showed mammalian-like nonsialyl complex-type N-glycosylation (Legardinier et al., 2005). Natural eCG contains
complex-type N-glycans terminating with both Siaα2,3Gal and Siaα2,6Gal. In previous
studies, we had reported rec-eCG production in CHO-K1 cells (Min et al., 2004; Park et al.,
2009, 2010; Jeoung et al., 2010). But, the specific glycosylation site is
very important for the secretion of rec-eCG in CHO-K1 cells (in preparation). Our
results accord to reports that rec-eCG was exhibited biologically activity (Min et al., 1996, 2004; Park et al., 2009,
2010). Taken together, these results
indicated that rec-eCG produced from mammalian cells could be useful for improving
the development of dominant and pre-ovulation follicles in non-equids.We also stably transfected CHO-K1 cells with rFSHR and rLH/CGR cDNAs. In previous
studies, rec-eCGβ/α was shown to have dual activity of both rFSHR and rLH/ CGR in
not-equids, but only LH-like activity in equid species (Park et al., 2009; 2010). However, there have been no reports on the internalization of
rec-eCGs in rFSHR and rLH/CGR. Our results demonstrated that receptors of rFSH and
rLH/CG were internalized in a time- and concentration-dependent manner by rec-eCGs.
However, when deglycosylated at the Asn56 of α-subunit, rec-eCG did not
induce the internalization of those receptors. Our results support the data from a
previous study that showed that the internalization and degradation of chemically
deglycosylated hCG (dghCG) was slower than that of hCG in MA-10 cells, and that this
effect was not due to its inability to stimulate cAMP production (Hoelscher et al., 1991). In fact, dghCG was not
capable of uncoupling the LH/CGR in Leydig tumor cells (Rebois and Fishman, 1983). In contrast to hCG, addition of
dghCG to 32P-labeled 293L cells resulted in little or no increase in the
phosphorylation of LH/CG receptors (Hipkin et al.,
1993). Based on the data presented, we suggested that the rate of the
mutant rec-eCG, which was deglycosylated at Asn56 of the α-subunit, was
not increased because of the conformation of the hormone-receptor complex. A
previous study suggested that four serine residues in the C-terminal tail of rLH/CGR
had distinct structural requirements for agonist-induced uncoupling and
agonist-induced internalization (Lazari et al.,
1998). A constitutive active mutant of hLH/CGR, hLH/CGR- L457R, was not
routed to the lysosomes, but was recycled to the cell; hormone degradation was
barely detectable (Galet and Ascoli, 2006).
Similarly, the removal or simultaneous mutation of two residues (Cys699
and Leu683) rerouted internalized hCG to a degradation pathway and
internalized hLHR to the lysosomes (Galet et al.,
2004). Replacement of all of the Ser/Thr residues in the
carboxyl-terminal tail and truncation of the domain containing these residues
completely inhibited vasoactive intestinal polypeptide (VIP)-stimulated
phosphorylation and receptor internalization (Langlet et al., 2005). This GPCR internalization has been shown to be
agonist-specific and G protein regulated kinase (GRK)-dependent (Hossain et al., 2009). This type of feedback
regulation is conventional, as it requires the activation of classic G proteins
(Kohout and Lefkowitz, 2003; Lodowski et al., 2003) as shown in Fig. 6. In the presented study, we showed that
deglycosylated rec-eCG did not induce agonist-stimulated internalization. Therefore,
we suggested that the glycosylation site in rec-eCG played a pivotal role in the
internalization of rFSHR and rLH/CGR. The established stable cells expressing rFSHR
and rLH/CGR could be utilize agonist-stimulated receptor internalization when
stimulated with rec-eCG mutants that were deglycosylated at other sites. Further
studies are required to conclusively determine whether internalization is indeed
responsible for the uncoupling of rFSHR and rLH/CGR. These activity will be analyze
the oocyte ovulation in vivo using mice.
Fig. 6
Pathways of internalization, recycling, degradation and endocytosis of G
protein-coupled receptors.
When receptor cells are exposed to a agonist, the responsiveness wanes with
time, in spite of the continuous presence of the agonist. It called to as
desensitization that occur at the level of the hormone receptor,
post-receptor steps. There are two categories of regulatory events.
Uncoupling is defined as a change in the functional properties of a constant
number of receptors. The other one is down-regulation defining as a
reduction in the density of cell surface receptors (Hipkin et al., 1993).
Pathways of internalization, recycling, degradation and endocytosis of G
protein-coupled receptors.
When receptor cells are exposed to a agonist, the responsiveness wanes with
time, in spite of the continuous presence of the agonist. It called to as
desensitization that occur at the level of the hormone receptor,
post-receptor steps. There are two categories of regulatory events.
Uncoupling is defined as a change in the functional properties of a constant
number of receptors. The other one is down-regulation defining as a
reduction in the density of cell surface receptors (Hipkin et al., 1993).
Authors: Janet D Lowe; Helen S Sanderson; Alexandra E Cooke; Mehrnoosh Ostovar; Elena Tsisanova; Sarah L Withey; Charles Chavkin; Stephen M Husbands; Eamonn Kelly; Graeme Henderson; Chris P Bailey Journal: Mol Pharmacol Date: 2015-05-26 Impact factor: 4.436